These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Molecular and transcriptional characterization of the novel 17p11.2-p12 amplicon in multiple myeloma. Fabris S; Todoerti K; Mosca L; Agnelli L; Intini D; Lionetti M; Guerneri S; Lambertenghi-Deliliers G; Bertoni F; Neri A Genes Chromosomes Cancer; 2007 Dec; 46(12):1109-18. PubMed ID: 17823926 [TBL] [Abstract][Full Text] [Related]
31. Plasma cell leukemia: update on biology and therapy. Mina R; D'Agostino M; Cerrato C; Gay F; Palumbo A Leuk Lymphoma; 2017 Jul; 58(7):1538-1547. PubMed ID: 27819179 [TBL] [Abstract][Full Text] [Related]
32. Genomic screening for genes silenced by DNA methylation revealed an association between RASD1 inactivation and dexamethasone resistance in multiple myeloma. Nojima M; Maruyama R; Yasui H; Suzuki H; Maruyama Y; Tarasawa I; Sasaki Y; Asaoku H; Sakai H; Hayashi T; Mori M; Imai K; Tokino T; Ishida T; Toyota M; Shinomura Y Clin Cancer Res; 2009 Jul; 15(13):4356-64. PubMed ID: 19549772 [TBL] [Abstract][Full Text] [Related]
33. Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns. Schinke C; Boyle EM; Ashby C; Wang Y; Lyzogubov V; Wardell C; Qu P; Hoering A; Deshpande S; Ryan K; Thanendrarajan S; Mohan M; Yarlagadda N; Khan M; Choudhury SR; Zangari M; van Rhee F; Davies F; Barlogie B; Morgan G; Walker BA Blood Cancer J; 2020 Jun; 10(6):70. PubMed ID: 32555163 [TBL] [Abstract][Full Text] [Related]
34. Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis. Jimenez-Zepeda VH; Dominguez-Martinez VJ Int J Hematol; 2009 Apr; 89(3):259-268. PubMed ID: 19326058 [TBL] [Abstract][Full Text] [Related]
35. Genomics and proteomics in multiple myeloma and Waldenström macroglobulinemia. Henry T; Fonseca R Curr Opin Hematol; 2007 Jul; 14(4):369-74. PubMed ID: 17534163 [TBL] [Abstract][Full Text] [Related]
36. Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia. Tessier C; LeBlanc R; Roy J; Trudel S; Côté J; Lalancette M; Boudreault JS; Lemieux-Blanchard É; Kaedbey R; Pavic M Cancer Med; 2024 Sep; 13(17):e70192. PubMed ID: 39225552 [TBL] [Abstract][Full Text] [Related]
37. Primary Plasma Cell Leukemia Associated with t(6;14)(p21;q32) and IGH Rearrangement: A Case Study and Review of the Literature. Cho SY; Lim G; Oh SH; Lee HJ; Suh JT; Lee J; Lee WI; Lee HG; Yoon HJ; Park TS Ann Clin Lab Sci; 2011; 41(3):277-81. PubMed ID: 22075513 [TBL] [Abstract][Full Text] [Related]
38. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment. Pérez-Andrés M; Almeida J; Martín-Ayuso M; Moro MJ; Martín-Nuñez G; Galende J; Borrego D; Rodríguez MJ; Ortega F; Hernandez J; Moreno I; Domínguez M; Mateo G; San Miguel JF; Orfao A; ; Leukemia; 2005 Mar; 19(3):449-55. PubMed ID: 15674420 [TBL] [Abstract][Full Text] [Related]
39. A gene transcription signature of obesity in breast cancer. Creighton CJ; Sada YH; Zhang Y; Tsimelzon A; Wong H; Dave B; Landis MD; Bear HD; Rodriguez A; Chang JC Breast Cancer Res Treat; 2012 Apr; 132(3):993-1000. PubMed ID: 21750966 [TBL] [Abstract][Full Text] [Related]
40. Plasma cell leukemia masquerading as ALL-L3--a case report. Tripathy K; Gouda KP; Chakrabarty S; Das AK; Mohanty R Indian J Pathol Microbiol; 2005 Apr; 48(2):221-3. PubMed ID: 16758674 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]